Ameneh Rezayof Selected Research

Morphine (MS Contin)

10/2021	Ventral tegmental area serotonin 5-HT1A receptors and corticolimbic cFos/BDNF/GFAP signaling pathways mediate dextromethorphan/morphine anti-allodynia.
11/2020	Morphine improved stress-induced amnesia and anxiety through interacting with the ventral hippocampal endocannabinoid system in rats.
10/2020	The involvement of ventral hippocampal microglial cells, but not cannabinoid CB1 receptors, in morphine-induced analgesia in rats.
1/2020	GABA-cannabinoid interplays in the dorsal hippocampus and basolateral amygdala mediate morphine-induced amnesia.
1/2019	Blockade of NMDA Receptors and Nitric Oxide Synthesis Potentiated Morphine-Induced Anti-Allodynia via Attenuating Pain-Related Amygdala pCREB/CREB Signaling Pathway.
1/2019	The blockade of 5-HT1A receptors in the ventral tegmental area inhibited morphine/dextromethorphan-induced analgesia in pain rat models.
11/2018	Medial Prefrontal Cortical Cannabinoid CB1 Receptors Mediate Morphine-Dextromethorphan Cross State-Dependent Memory: The Involvement of BDNF/cFOS Signaling Pathways.
1/2018	Interactive effects of morphine and nicotine on memory function depend on the central amygdala cannabinoid CB1 receptor function in rats.
1/2017	Neuromodulatory effects of the dorsal hippocampal endocannabinoid system in dextromethorphan/morphine-induced amnesia.
2/2016	Role of hippocampal and prefrontal cortical signaling pathways in dextromethorphan effect on morphine-induced memory impairment in rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ameneh Rezayof Research Topics

Disease

34	Amnesia (Dissociative Amnesia) 08/2022 - 08/2004
6	Pain (Aches) 10/2020 - 01/2014
3	Hyperalgesia 10/2021 - 01/2014
3	Memory Disorders (Memory Loss) 10/2019 - 08/2011
2	Neuralgia (Stump Neuralgia) 10/2021 - 01/2019
2	Cough 01/2017 - 02/2016
1	Acute Pain 10/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 10/2019
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Hypothermia 06/2013
1	Cholestasis 06/2013
1	Shock 07/2008

Drug/Important Bio-Agent (IBA)

29	Morphine (MS Contin)FDA LinkGeneric 10/2021 - 08/2004
11	Nicotine FDA Link 10/2019 - 01/2006
8	CannabinoidsIBA 10/2020 - 05/2010
7	N-Methylaspartate (NMDA)IBA 01/2019 - 12/2008
7	SCH 23390IBA 04/2012 - 08/2004
6	Ethanol (Ethyl Alcohol)IBA 01/2019 - 12/2008
6	AM 251 (AM251)IBA 11/2018 - 03/2013
6	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2018 - 09/2011
6	Sulpiride (neogama)IBA 05/2010 - 08/2004
4	MuscimolIBA 08/2022 - 01/2006
4	Scopolamine (Hyoscine)FDA Link 01/2020 - 04/2012
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 07/2007
4	Pharmaceutical PreparationsIBA 04/2012 - 06/2006
3	Dextromethorphan (Racemethorphan)FDA LinkGeneric 10/2021 - 01/2017
3	EndocannabinoidsIBA 11/2020 - 01/2017
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 10/2019 - 04/2012
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2015
3	Arginine (L-Arginine)FDA Link 01/2019 - 06/2006
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019 - 06/2006
3	Glutamic Acid (Glutamate)FDA Link 01/2019 - 06/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 06/2006
3	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 04/2012 - 08/2004
3	Opioid Analgesics (Opioids)IBA 06/2010 - 08/2005
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2022 - 10/2021
2	Minocycline (Cyclops)FDA LinkGeneric 10/2020 - 10/2015
2	LithiumIBA 05/2020 - 12/2009
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2019 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 01/2014
2	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 04/2012 - 06/2006
2	Dopamine Receptors (Dopamine Receptor)IBA 08/2011 - 08/2005
2	Apomorphine FDA Link 05/2010 - 06/2006
2	MecamylamineIBA 07/2008 - 01/2006
2	BicucullineIBA 03/2008 - 01/2006
2	QuinpiroleIBA 01/2006 - 08/2004
2	Naloxone (Narcan)FDA LinkGeneric 08/2005 - 08/2004
1	GABA-A Receptors (GABA(A) Receptor)IBA 08/2022
1	Glial Fibrillary Acidic ProteinIBA 10/2021
1	Serotonin (5 Hydroxytryptamine)IBA 10/2021
1	Olanzapine (Zyprexa)FDA Link 05/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 10/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	SDMIBA 11/2018
1	arachidonylcyclopropylamideIBA 01/2018
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 08/2017
1	Tamoxifen FDA LinkGeneric 01/2016
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2016
1	ProteomeIBA 01/2015
1	KATP ChannelsIBA 01/2014
1	Nimodipine (Modus)FDA LinkGeneric 01/2014
1	Diazoxide (Hyperstat)FDA Link 01/2014
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 06/2013
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2010
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2008
1	Baclofen FDA LinkGeneric 03/2008
1	Dizocilpine Maleate (Dizocilpine)IBA 06/2006
1	PhysostigmineIBA 01/2006
1	Atropine FDA LinkGeneric 01/2006
1	Cholinergic Agents (Cholinergics)IBA 01/2006

Therapy/Procedure

7	Injections 11/2018 - 08/2004
3	Analgesia 10/2020 - 01/2015
1	Therapeutics 01/2016
1	Adjuvant Chemotherapy 01/2016
1	Induced Hypothermia 06/2013
1	Ligation 06/2013
1	Cannula 07/2008